A glucose-sensitive nanovaccine delivers CRISPR to tumors, silences immune-suppressing genes, and activates a targeted immune response against cancer. (Nanowerk Spotlight) Immune-based cancer ...
Scientists are always working to improve cancer treatment so that it’s quicker, safer and more effective for patients. And it seems researchers at the University of California-San Francisco have made ...
Cervical cancer screenings are considered one of the most significant public health advances of the past 50 years, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results